Selected Start-Ups Founded in 2000 (03/00)
Executive Summary
{In Vivo} summarizes the technologies of several recently founded companies: Netherlands start-up [BioMaDe BV] will use nanotechnology to design and construct molecular devices for use in a variety of commercial applications. [DirectGene Inc.] is developing a tissue specific gene promoter technology for cancer gene therapy, based on the role of tumor-stromal interactions. [Esurg.com] will sell medical, surgical and pharmaceutical supplies and information to out-of-hospital healthcare providers. Founded in June 1999, [ImmunoGenec Biotechnologie GmbH] aims to develop, produce and market protein-based therapies for the immunotherapeutic treatment of certain cancers. [Quorex Pharmaceuticals Inc.] will discover anti-infectives using its discovery of a novel signaling pathway that occurs in wide variety of pathogenic bacteria. A joint venture of Rohm & Haas Co. and Argonex Inc, [RHeoGene LLC.] is developing enabling gene tools based on its proprietary Ecdyosyne Recepter-based gene switch system.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.